BRENTUXIMAB VEDOTIN VS PHYSICIAN'S CHOICE IN CTCL PATIENTS...

Hematological Oncology 2017 / 06 Vol. 35

BRENTUXIMAB VEDOTIN VS PHYSICIAN'S CHOICE IN CTCL PATIENTS FROM THE PHASE 3 ALCANZA STUDY: ANALYSIS OF OUTCOMES BY CD30 EXPRESSION

Kim, Y.H., Prince, H.M., Whittaker, S., Horwitz, S.M., Duvic, M., Scarisbrick, J., Quaglino, P., Zinzani, P.L., Wolter, P., Bechter, O., Wang, Y., Palanca-Wessels, M.C., Wood, K.W., Li, M., Liu, Y., L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_65
Date:
June, 2017
File:
PDF, 90 KB
english, 2017
Conversion to is in progress
Conversion to is failed